Impaired β-cell function in human aging: Response to nicotinic acid-induced insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 9, 2006, Pages 3303-3309

  Chang, Annette M ^a,c   Smith, Marla J ^b   Galecki, Andrzej T ^b   Bloem, Cathie J ^b   Halter, Jeffrey B ^b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c 5570 MSRB II ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; NICOTINIC ACID;

ADULT; AGED; AGING; AREA UNDER THE CURVE; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 33748757327     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0913     Document Type: Article

References (32)

1. Chang AM, Halter JB 2003 Aging and insulin secretion. Am J Physiol Endocrinol Metab 284:E7-E12
2. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD 1998 Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524
3. Resnick HE, Harris MI, Brock DB, Harris TB 2000 American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 23:176-180
4. Weyer C, Bogardus C, Mott DM, Pratley RE 1999 The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794
5. Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, Basu A, Vittone JL, Klee GG, Arora P, Jensen MD, Toffolo G, Cobelli C, Rizza RA 2003 Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 52:1738-1748
6. Miettinen TA, Taskinen MR, Pelkonen R, Nikkila EA 1969 Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid. Acta Med Scand 186:247-253
7. Boden G, Chen X, Iqbal N 1998 Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes 47:1609-1612
8. Haffner SM, Miettinen H, Stern MP, Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H 1997 The homeostasis model in the San Antonio Heart Study: a prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 20:1087-1092
9. Tornvall P, Walldius G 1991 A comparison between nicotinic acid and acipimox in hypertriglyceridaemia - effects on serum lipids, lipoproteins, glucose tolerance and tolerability. J Intern Med 230:415-421
10. Gaut ZN, Pocelinko R, Solomon HM, Thomas GB 1971 Oral glucose tolerance, plasma insulin, and uric acid excretion in man during chronic administration of nicotinic acid. Metabolism 20:1031-1035
11. Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky Jr GJ, Porte Jr D 1989 Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38:562-568
12. Bergman RN 1989 Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38:1512-1527
13. Yang YJ, Youn JH, Bergman RN 1987 Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 253:E595-E602
14. Ahren B, Pacini G 2004 Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess β cell function in clinical studies. Eur J Endocrinol 150:97-104
15. Bergman RN, Phillips LS, Cobelli C 1981 Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467
16. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte Jr D 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
17. Chang AM, Jakobsen G, Sturis J, Smith MJ, Bloem CJ, An B, Galecki A, Halter JB 2003 The GLP-1 derivative NN2211 restores β-cell sensitivity to glucose in type 2 diabetic patients after a single dose. Diabetes 52:1786-1791
18. Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB 2004 Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance. Am J Physiol Endocrinol Metab 287:E906-E911
19. Van Cauter E, Mestrez F, Sturis J, Polonsky KS 1992 Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
20. Evans MI, Halter JB, Porte Jr D 1978 Comparison of double- and single-isotope enzymatic derivative methods for measuring catecholamines in human plasma. Clin Chem 24:567-570
21. Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB, Supiano MA 2006 Limitation of the homeostasis model assessment to predict insulin resistance and β-cell dysfunction in older people. J Clin Endocrinol Metab 91:629-634
22. Utzschneider KM, Carr DB, Hull RL, Kodama K, Shofer JB, Retzlaff BM, Knopp RH, Kahn SE 2004 Impact of intra-abdominal fat and age on insulin sensitivity and β-cell function. Diabetes 53:2867-2872
23. Chen M, Bergman RN, Pacini G, Porte Jr D 1985 Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function. J Clin Endocrinol Metab 60:13-20
24. Feldman JM, Plonk JW 1976 Effect of age on intravenous glucose tolerance and insulin secretion. J Am Geriatr Soc 24:1-3
25. Palmer JP, Ensinck JW 1975 Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J Clin Endocrinol Metab 41:498-503
26. Ahren B, Pacini G 1998 Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J Clin Endocrinol Metab 83:3350-3356
27. Kahn SE, Larson VG, Schwartz RS, Beard JC, Cain KC, Fellingham GW, Stratton JR, Cerqueira MD, Abrass IB 1992 Exercise training delineates the importance of B-cell dysfunction to the glucose intolerance of human aging. J Clin Endocrinol Metab 74:1336-1342
28. Rasouli N, Hale T, Kahn SE, Spencer HJ, Elbein SC 2005 Effects of short-term experimental insulin resistance and family history of diabetes on pancreatic β-cell function in nondiabetic individuals. J Clin Endocrinol Metab 90:5825-5833
29. Korosi J, McIntosh CH, Pederson RA, Demuth HU, Habener JF, Gingerich R, Egan JM, Elahi D, Meneilly GS 2001 Effect of aging and diabetes on the enteroinsular axis. J Gerontol A Biol Sci Med Sci 56:M575-M579
30. Meneilly GS, Ryan AS, Minaker KL, Elahi D 1998 The effect of age and glycemic level on the response of the β-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin. J Clin Endocrinol Metab 83:2925-2932
31. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K 2003 A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461-2474
32. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U 1996 Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45:947-953